These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

479 related items for PubMed ID: 21892075

  • 21. Efficacy and safety of probiotics in irritable bowel syndrome: A systematic review and meta-analysis.
    Sun JR, Kong CF, Qu XK, Deng C, Lou YN, Jia LQ.
    Saudi J Gastroenterol; 2020; 26(2):66-77. PubMed ID: 31898645
    [Abstract] [Full Text] [Related]

  • 22. The rationale and clinical effectiveness of probiotics in irritable bowel syndrome.
    Ringel Y, Ringel-Kulka T.
    J Clin Gastroenterol; 2011 Nov; 45 Suppl():S145-8. PubMed ID: 21992954
    [Abstract] [Full Text] [Related]

  • 23. Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double-blind, placebo-controlled, multicenter, phase II trial.
    Choi CH, Kwon JG, Kim SK, Myung SJ, Park KS, Sohn CI, Rhee PL, Lee KJ, Lee OY, Jung HK, Jee SR, Jeen YT, Choi MG, Choi SC, Huh KC, Park H.
    Neurogastroenterol Motil; 2015 May; 27(5):705-16. PubMed ID: 25809913
    [Abstract] [Full Text] [Related]

  • 24. Emerging role of probiotics and antimicrobials in the management of irritable bowel syndrome.
    Cash BD.
    Curr Med Res Opin; 2014 Jul; 30(7):1405-15. PubMed ID: 24666019
    [Abstract] [Full Text] [Related]

  • 25. Constipation-Predominant Irritable Bowel Syndrome (IBS-C): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms.
    Di Rosa C, Altomare A, Terrigno V, Carbone F, Tack J, Cicala M, Guarino MPL.
    Nutrients; 2023 Mar 28; 15(7):. PubMed ID: 37049488
    [Abstract] [Full Text] [Related]

  • 26. The gut microbiome and irritable bowel syndrome: State of art review.
    Salem AE, Singh R, Ayoub YK, Khairy AM, Mullin GE.
    Arab J Gastroenterol; 2018 Sep 28; 19(3):136-141. PubMed ID: 29935865
    [Abstract] [Full Text] [Related]

  • 27. Probiotics in Irritable Bowel Syndrome: An Up-to-Date Systematic Review.
    Dale HF, Rasmussen SH, Asiller ÖÖ, Lied GA.
    Nutrients; 2019 Sep 02; 11(9):. PubMed ID: 31480656
    [Abstract] [Full Text] [Related]

  • 28. Dysbiosis in Functional Bowel Disorders.
    Enck P, Mazurak N.
    Ann Nutr Metab; 2018 Sep 02; 72(4):296-306. PubMed ID: 29694952
    [Abstract] [Full Text] [Related]

  • 29. Probiotics, Prebiotics, and Synbiotics: Implications and Beneficial Effects against Irritable Bowel Syndrome.
    Simon E, Călinoiu LF, Mitrea L, Vodnar DC.
    Nutrients; 2021 Jun 20; 13(6):. PubMed ID: 34203002
    [Abstract] [Full Text] [Related]

  • 30. Editorial: The importance of systematic reviews and meta-analyses of probiotics and prebiotics.
    Whelan K.
    Am J Gastroenterol; 2014 Oct 20; 109(10):1563-5. PubMed ID: 25287086
    [Abstract] [Full Text] [Related]

  • 31. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.
    Barbara G, Zecchi L, Barbaro R, Cremon C, Bellacosa L, Marcellini M, De Giorgio R, Corinaldesi R, Stanghellini V.
    J Clin Gastroenterol; 2012 Oct 20; 46 Suppl():S52-5. PubMed ID: 22955358
    [Abstract] [Full Text] [Related]

  • 32. Prebiotics, probiotics and digestive health.
    Balakrishnan M, Floch MH.
    Curr Opin Clin Nutr Metab Care; 2012 Nov 20; 15(6):580-5. PubMed ID: 23037903
    [Abstract] [Full Text] [Related]

  • 33. Treatment of irritable bowel syndrome.
    Trinkley KE, Nahata MC.
    J Clin Pharm Ther; 2011 Jun 20; 36(3):275-82. PubMed ID: 21545610
    [Abstract] [Full Text] [Related]

  • 34. Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use.
    Barbara G, Stanghellini V, Cremon C, De Giorgio R, Gargano L, Cogliandro R, Pallotti F, Corinaldesi R.
    J Clin Gastroenterol; 2008 Sep 20; 42 Suppl 3 Pt 2():S214-7. PubMed ID: 18685517
    [Abstract] [Full Text] [Related]

  • 35. Antibiotics, probiotics and prebiotics in IBD.
    Bernstein CN.
    Nestle Nutr Inst Workshop Ser; 2014 Sep 20; 79():83-100. PubMed ID: 25227297
    [Abstract] [Full Text] [Related]

  • 36. Are probiotics or prebiotics useful in pediatric irritable bowel syndrome or inflammatory bowel disease?
    Guandalini S.
    Front Med (Lausanne); 2014 Sep 20; 1():23. PubMed ID: 25593899
    [Abstract] [Full Text] [Related]

  • 37. Probiotics, Prebiotics, and Synbiotics in the Irritable Bowel Syndrome Treatment: A Review.
    Chlebicz-Wójcik A, Śliżewska K.
    Biomolecules; 2021 Aug 04; 11(8):. PubMed ID: 34439821
    [Abstract] [Full Text] [Related]

  • 38. Targeting the Microbiota, from Irritable Bowel Syndrome to Mood Disorders: Focus on Probiotics and Prebiotics.
    Pusceddu MM, Murray K, Gareau MG.
    Curr Pathobiol Rep; 2018 Mar 04; 6(1):1-13. PubMed ID: 29785336
    [Abstract] [Full Text] [Related]

  • 39. Alteration of the intestinal microbiota as a cause of and a potential therapeutic option in irritable bowel syndrome.
    König J, Brummer RJ.
    Benef Microbes; 2014 Sep 04; 5(3):247-61. PubMed ID: 24583610
    [Abstract] [Full Text] [Related]

  • 40. Efficacy of Probiotics for Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis.
    Zhang T, Zhang C, Zhang J, Sun F, Duan L.
    Front Cell Infect Microbiol; 2022 Sep 04; 12():859967. PubMed ID: 35433498
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.